» Authors » Kenichi Harada

Kenichi Harada

Explore the profile of Kenichi Harada including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 435
Citations 5292
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Tanaka A, Harada K
Hepatol Int . 2024 Aug; 18(5):1385-1395. PMID: 39127981
Acute presentation of autoimmune hepatitis (AIH) occurs in 22-43% of all AIH cases, and is not a rare condition. Rather than constituting a single disease entity, it represents a clinical...
12.
Minato A, Furubayashi N, Tomoda T, Hori Y, Kiyoshima K, Negishi T, et al.
Transl Androl Urol . 2024 Aug; 13(7):1118-1126. PMID: 39100842
Background: The subtype of urothelial carcinoma (SUC) has been known to possess morphological diversity for histologic subtype or divergent differentiation. However, the efficacy of avelumab against SUC remains unclear. Therefore,...
13.
Minato A, Furubayashi N, Tomoda T, Masaoka H, Song Y, Hori Y, et al.
Anticancer Res . 2024 Jul; 44(8):3419-3426. PMID: 39060065
Background/aim: This study retrospectively evaluated whether enfortumab vedotin (EV) monotherapy is effective as a late-line treatment according to prior treatment type in patients with advanced urothelial carcinoma (UC). Patients And...
14.
Furubayashi N, Minato A, Tomoda T, Masaoka H, Hori Y, Kiyoshima K, et al.
Anticancer Res . 2024 Jul; 44(8):3409-3417. PMID: 39060060
Background/aim: The efficacy, safety, and liver toxicity of enfortumab vedotin (EV) for elderly advanced urothelial carcinoma (UC) patients and patients with a poor performance status (PS) are unclear. Patients And...
15.
Minato A, Furubayashi N, Tomoda T, Masaoka H, Song Y, Hori Y, et al.
Clin Genitourin Cancer . 2024 Jul; 22(5):102148. PMID: 39033710
Introduction: To evaluate the organ-specific therapeutic effect of enfortumab vedotin (EV) after chemotherapy and immunotherapy failed for advanced urothelial carcinoma. Materials Methods: At 6 institutions between December 2021 and July...
16.
Katano K, Nakanuma S, Tokoro T, Takei R, Takada S, Okazaki M, et al.
J Hepatobiliary Pancreat Sci . 2024 Jul; 31(10):705-715. PMID: 39011821
Background: The detailed mechanisms underlying the development of ischemia-type biliary lesions (ITBLs) in aged donor grafts remain unclear. In the present study we aimed to investigate the impact of aging...
17.
Nakanuma Y, Kakuda Y, Nguyen Canh H, Sasaki M, Harada K, Sugino T
Virchows Arch . 2024 Jul; 485(2):257-268. PMID: 39008118
The peribiliary capillary plexus (PCP) regularly and densely lines the basal side of the lining epithelia of normal bile ducts. To determine the pathology of the PCP in high-grade biliary...
18.
Nambu K, Kinoshita M, Sato Y, Tamai S, Nakajima R, Harada K, et al.
J Neurosurg Case Lessons . 2024 Jul; 8(2). PMID: 38976915
Background: Hypofractionated radiotherapy with temozolomide is recommended for older patients with glioblastoma. Nevertheless, a potential complication of treatment is opportunistic infections with immunosuppression. Observations: An 86-year-old man presented with hemiparesis,...
19.
Li Z, Nguyen Canh H, Takahashi K, Le Thanh D, Nguyen Thi Q, Yang R, et al.
Med Mol Morphol . 2024 Jul; 57(3):200-217. PMID: 38960952
Intrahepatic cholangiocarcinoma (iCCA) exhibits different blood imaging features and prognosis depending on histology. To clarity histopathological growth patterns (HGPs) and vascularization processes of iCCA, we collected 145 surgical specimens and...
20.
Nagata Y, Quynh N, Aono H, Harada K, Miyamoto H, Fujimoto N
Cancer Genomics Proteomics . 2024 Jun; 21(4):388-394. PMID: 38944424
Background/aim: The efficacy of melatonin and its biological significance in human bladder cancer remain poorly understood. This study aimed to investigate the functional role of melatonin in urothelial carcinogenesis. Materials...